Diagnostic reproducibility of tumour budding in colorectal cancer: a multicentre, multinational study using virtual microscopy

DSpace/Manakin Repository

Diagnostic reproducibility of tumour budding in colorectal cancer: a multicentre, multinational study using virtual microscopy

Citable link to this page

 

 
Title: Diagnostic reproducibility of tumour budding in colorectal cancer: a multicentre, multinational study using virtual microscopy
Author: Puppa, Giacomo; Senore, Carlo; Sheahan, Kieran; Vieth, Michael; Lugli, Alessandro; Zlobec, Inti; Pecori, Sara; Wang, Lai Mun; Langner, Cord; Mitomi, Hiroyuki; Nakamura, Takatoshi; Watanabe, Masahiko; Ueno, Hideki; Chasle, Jacques; Conley, Stephen A; Herlin, Paulette; Lauwers, Gregory Y.; Risio, Mauro

Note: Order does not necessarily reflect citation order of authors.

Citation: Puppa, Giacomo, Carlo Senore, Kieran Sheahan, Michael Vieth, Alessandro Lugli, Inti Zlobec, Sara Pecori, et al. 2012. “Diagnostic Reproducibility of Tumour Budding in Colorectal Cancer: a Multicentre, Multinational Study Using Virtual Microscopy.” Histopathology 61 (4) (July 5): 562–575. Portico. doi:10.1111/j.1365-2559.2012.04270.x.
Access Status: Full text of the requested work is not available in DASH at this time (“dark deposit”). For more information on dark deposits, see our FAQ.
Full Text & Related Files:
Abstract: Aims:  Despite the established prognostic relevance of tumour budding in colorectal cancer, the reproducibility of the methods reported for its assessment has not yet been determined, limiting its use and reporting in routine pathology practice.
Methods and results:  A morphometric system within telepathology was devised to evaluate the reproducibility of the various methods published for the assessment of tumour budding in colorectal cancer. Five methods were selected to evaluate the diagnostic reproducibility among 10 investigators, using haematoxylin and eosin (H&E) and AE1-3 cytokeratin-immunostained, whole-slide digital scans from 50 pT1–pT4 colorectal cancers. The overall interobserver agreement was fair for all methods, and increased to moderate for pT1 cancers. The intraobserver agreement was also fair for all methods and moderate for pT1 cancers. Agreement was dependent on the participants’ experience with tumour budding reporting and performance time. Cytokeratin immunohistochemistry detected a higher percentage of tumour budding-positive cases with all methods compared to H&E-stained slides, but did not influence agreement levels.
Conclusions:  An overall fair level of diagnostic agreement for tumour budding in colorectal cancer was demonstrated, which was significantly higher in early cancer and among experienced gastrointestinal pathologists. Cytokeratin immunostaining facilitated detection of budding cancer cells, but did not result in improved interobserver agreement.
Published Version: doi:10.1111/j.1365-2559.2012.04270.x
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:35140975
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters